| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $7,291,821 ) (Continued on the next page) |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R34MH126702 | Building Resources to Achieve Improvement in Neurocognition (B.R.A.I.N.) inpeople with HIV. | 000 | 1 | NIH | 3/23/2022 | $151,622 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 000 | 16 | NIH | 11/30/2021 | $472,339 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 001 | 16 | NIH | 6/15/2022 | $3,436 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 001 | 16 | NIH | 6/15/2022 | $692,846 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 001 | 16 | NIH | 6/15/2022 | $301,987 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | D43TW011308 | Building Research in Inter-Disciplinary Gender and HIV through the Social Sciences (The BRIDGES Programme) | 000 | 4 | NIH | 3/11/2022 | $37,500 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | D43TW011308 | Building Research in Inter-Disciplinary Gender and HIV through the Social Sciences (The BRIDGES Programme) | 000 | 4 | NIH | 3/11/2022 | $50,000 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | D43TW011308 | Building Research in Inter-Disciplinary Gender and HIV through the Social Sciences (The BRIDGES Programme) | 000 | 4 | NIH | 3/11/2022 | $214,727 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | D43TW010559 | HIV-associated Tuberculosis Training Program (HATTP) | 001 | 6 | NIH | 3/22/2022 | $296,981 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | D43TW010559 | HIV-associated Tuberculosis Training Program (HATTP) | 002 | 6 | NIH | 3/31/2022 | $50,000 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | D43TW010559 | HIV-associated Tuberculosis Training Program (HATTP) | 002 | 6 | NIH | 3/31/2022 | -$50,000 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R01AI143521 | New tools for antimalarial target identification | 000 | 4 | NIH | 3/1/2022 | $141,155 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | K43TW011434 | Undetectable and Untransmittable: reducing HIV transmission among young women living with HIV, their partners and children in South Africa | 000 | 4 | NIH | 4/22/2022 | $50,000 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | K43TW011434 | Undetectable and Untransmittable: reducing HIV transmission among young women living with HIV, their partners and children in South Africa | 000 | 4 | NIH | 4/22/2022 | $51,076 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | K43TW011421 | Characterizing the pharmacokinetics of high dose rifampicin and linezolid in a randomized controlled trial for HIV-associated tuberculous meningitis | 000 | 4 | NIH | 6/3/2022 | $107,813 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | K43TW011442 | Psychosocial distress, inflammatory reactivity and central sensitization in the pathway to HIV-related pain: characterizing the associations and developing a pragmatic, coping-focused intervention. | 000 | 4 | NIH | 4/15/2022 | $113,289 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U01AI152103 | Influence of high-dose rifampin on Mycobacterial load and inflammatory mediators in pericardial TB patients | 000 | 3 | NIH | 4/29/2022 | $199,994 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R01AI152118 | Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate. | 000 | 3 | NIH | 4/27/2022 | $153,254 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R01AI152118 | Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate. | 000 | 3 | NIH | 4/27/2022 | $192,500 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U01AI152151 | Characterizing intact proviral HIV-1 reservoir size and determinants of reservoir dynamics in African populations | 002 | 3 | NIH | 3/31/2022 | $182,181 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 000 | 3 | NIH | 4/12/2022 | $56,969 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R01AI152115 | Antigenic and virological traits of HIV-1 breakthrough infections in the VRC01 antibody-mediated prevention Phase 2b trial in sub-Saharan Africa | 000 | 3 | NIH | 4/12/2022 | $279,450 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U01AI152153 | Maximizing the success of HIV+ to HIV+ kidney transplantation in South Africa | 000 | 3 | NIH | 4/1/2022 | $180,209 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R01CA250011 | Automated Visual Evaluation for Cervical Cancer Screening in HIV-positive Women | 000 | 3 | NIH | 5/27/2022 | $191,597 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R01CA250011 | Automated Visual Evaluation for Cervical Cancer Screening in HIV-positive Women | 000 | 3 | NIH | 5/27/2022 | $144,328 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R01AI152092 | Repurposing kinase inhibitor chemotypes as antimalarials | 000 | 3 | NIH | 3/31/2022 | $178,500 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R01AI152092 | Repurposing kinase inhibitor chemotypes as antimalarials | 000 | 3 | NIH | 3/31/2022 | $125,592 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R01AI160501 | Targeting non-coding RNAs as host-directed drug therapy for tuberculosis | 000 | 2 | NIH | 4/21/2022 | $132,596 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R61DA053736 | Cape Town Adolescent Antiretroviral Cohort- Substance, Imaging, Mental Health (CTAAC-SIM) | 001 | 2 | NIH | 6/17/2022 | $358,935 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | K43TW011943 | Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa | 001 | 2 | NIH | 4/20/2022 | $50,000 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | K43TW011943 | Zikhethele - choose for you: evaluating choice-based antiretroviral therapy support for patients returning to HIV care after treatment interruption in South Africa | 001 | 2 | NIH | 4/20/2022 | $46,766 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U01MH125053 | 3/3 Genomics of Schizophrenia in the South African Xhosa | 000 | 2 | NIH | 2/7/2022 | $699,695 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U01MH125053 | 3/3 Genomics of Schizophrenia in the South African Xhosa | 001 | 2 | NIH | 6/3/2022 | $77,743 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | K43TW011986 | Defining the biology of HIV-associated aggressive B-cell lymphoma in Southern Africa | 000 | 2 | NIH | 5/5/2022 | $104,575 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | R25TW012219 | Establishing an MSc in Global Health Ethics at the University of Cape Town | 000 | 1 | NIH | 3/18/2022 | $215,271 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 000 | 16 | NIH | 11/30/2021 | $1,083,682 |
| | 2022 | 2022 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | UM1AI069519 | HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027 | 000 | 16 | NIH | 11/30/2021 | $5,375 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | ORIIR210072 | 7th World Conference on Research Integrity | 02 | 1 | DHHS/OS | 3/28/2022 | $46,282 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | ORIIR210072 | 7th World Conference on Research Integrity | 01 | 1 | DHHS/OS | 3/17/2022 | -$46,282 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | province | | | ZAF | ORIIR210072 | 7th World Conference on Research Integrity | 03 | 1 | DHHS/OS | 4/11/2022 | -$46,282 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | province | | | ZAF | ORIIR210072 | 7th World Conference on Research Integrity | 04 | 1 | DHHS/OS | 4/19/2022 | $46,282 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U24HL135600 | Sickle Africa Data Coordinating Center | 002 | 5 | NIH | 4/20/2022 | $426,645 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | D43TW010559 | HIV-associated Tuberculosis Training Program (HATTP) | 000 | 5 | NIH | 3/15/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U54HG009790 | Individual Findings in Genetic Research in Africa (IFGeneRA) | 000 | 5 | NIH | 3/16/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U54HG009824 | Center for Research on the Respiratory Microbiota of African Children (ReMAC) | 000 | 5 | NIH | 10/28/2021 | $0 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U54HG009824 | Center for Research on the Respiratory Microbiota of African Children (ReMAC) | 000 | 5 | NIH | 10/28/2021 | $0 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U01HG009716 | Hearing Impairment Genetics Studies in Africa (HI-GENES Africa) | 000 | 5 | NIH | 5/11/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U01HG009716 | Hearing Impairment Genetics Studies in Africa (HI-GENES Africa) | 000 | 5 | NIH | 5/11/2022 | $0 |
| | 2022 | 2021 | UNIVERSITY OF CAPE TOWN | LOVERS WALK | RONDEBOSCH | | | | ZAF | U24HG006941 | H3ABioNet: informatics solutions for H3Africa | 000 | 10 | NIH | 1/6/2022 | $0 |
|
